| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dendritic cell vaccine | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cancer of Head and Neck[MeSHID:D006258] Antigen-Presenting Cells[MeSHID:D000938] |
NA | phase 2 | unknown |
| dendritic cell vaccine | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Malignant neoplasm of ovary[MeSHID:D010051] |
NA | phase 2 | unknown |
| dendritic cell vaccine | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Glioblastoma[MeSHID:D005909] |
NA | phase 2 | unknown |
| dendritic cell vaccine | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | phase 2 | unknown |
| dendritic cell vaccine | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Malignant neoplasm of ovary[MeSHID:D010051] |
NA | phase 1 | unknown |
| dendritic cell vaccine | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cancer of Head and Neck[MeSHID:D006258] Antigen-Presenting Cells[MeSHID:D000938] |
NA | phase 1 | unknown |
| dendritic cell vaccine | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Glioblastoma[MeSHID:D005909] |
NA | phase 1 | unknown |
| dendritic cell vaccine | cellular tumor antigen p53 | NA | Clinical trial target | TTD , DGIDB | Dendritic Cells[MeSHID:D003713] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Antigen-Presenting Cells[MeSHID:D000938] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||